These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32088612)

  • 1. LINE-1 retrotransposon encoded ORF1p expression and promoter methylation in oral squamous cell carcinoma: a pilot study.
    Budania S; Sur D; Nangal J; Pilli S; Mukherjee K; Biswas M; Prasad R; Saxena S; Mandal PK
    Cancer Genet; 2020 Jun; 244():21-29. PubMed ID: 32088612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma.
    Mukherjee K; Sur D; Singh A; Rai S; Das N; Sekar R; Narindi S; Dhingra VK; Jat B; Balraam KVV; Agarwal SP; Mandal PK
    BMC Cancer; 2021 May; 21(1):628. PubMed ID: 34044801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nucleolin Antagonist N6L Inhibits LINE1 Retrotransposon Activity in Non-Small Cell Lung Carcinoma Cells.
    Ramos KS; Moore S; Runge I; Tavera-Garcia MA; Cascone I; Courty J; Reyes-Reyes EM
    J Cancer; 2020; 11(3):733-740. PubMed ID: 31942196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer.
    Chen L; Dahlstrom JE; Chandra A; Board P; Rangasamy D
    Breast Cancer Res Treat; 2012 Nov; 136(1):129-42. PubMed ID: 23053642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing Complex Nucleic Acid Interactions of LINE1 ORF1p by Single Molecule Force Spectroscopy.
    Naufer MN; Williams MC
    Methods Mol Biol; 2020; 2106():283-297. PubMed ID: 31889265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.
    Foy JP; Pickering CR; Papadimitrakopoulou VA; Jelinek J; Lin SH; William WN; Frederick MJ; Wang J; Lang W; Feng L; Zhang L; Kim ES; Fan YH; Hong WK; El-Naggar AK; Lee JJ; Myers JN; Issa JP; Lippman SM; Mao L; Saintigny P
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1027-35. PubMed ID: 26342026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter-associated DNA methylation & expression profiling of genes (
    Khongsti S; Shunyu BN; Ghosh S
    Indian J Med Res; 2019 Dec; 150(6):584-591. PubMed ID: 32048621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
    Reddy VR; Annamalai T; Narayanan V; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
    Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
    Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY.
    Zhang R; Zhang F; Sun Z; Liu P; Zhang X; Ye Y; Cai B; Walsh MJ; Ren X; Hao X; Zhang W; Yu J
    Cancer Res; 2019 Sep; 79(17):4453-4465. PubMed ID: 31289132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
    Clausen MJ; Melchers LJ; Mastik MF; Slagter-Menkema L; Groen HJ; van der Laan BF; van Criekinge W; de Meyer T; Denil S; Wisman GB; Roodenburg JL; Schuuring E
    Genes Chromosomes Cancer; 2016 Jan; 55(1):45-59. PubMed ID: 26391330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.
    Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP
    Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of L1-Ribonucleoprotein Particles (L1-RNPs) from Cultured Human Cells.
    Mandal PK; Kazazian HH
    Methods Mol Biol; 2016; 1400():299-310. PubMed ID: 26895061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Zhang J; Ling T; Wu H; Wang K
    J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.